Antiandrogen Therapy trials for Prostate cancer

All Antiandrogen Therapy trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Antiandrogen Therapy for Prostate cancer

• Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
  NCT04947254 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
  NCT06244004 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 6 locations
• Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
  NCT07202247 · Phase: Phase 2 · Ages: 30 Years to 79 Years · Sex: Male · 1 location
• SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
  NCT06205316 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 6 locations

Common questions

How many trials study Antiandrogen Therapy for Prostate cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.